Cargando…
Pretreatment with antiplatelet drugs improves the cardiac function after myocardial infarction without reperfusion in a mouse model
BACKGROUND: Reperfusion therapy is known to improve prognosis and limit myocardial damage after myocardial infarction (MI). The administration of antiplatelet drugs prior to percutaneous coronary intervention also proves beneficial to patients with acute MI (AMI). However, a good number of AMI patie...
Autores principales: | Zhang, Kandi, Yang, Wenlong, Zhang, Mingliang, Sun, Yaping, Zhang, Tiantian, Liu, Junling, Zhang, Junfeng |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Via Medica
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8105067/ https://www.ncbi.nlm.nih.gov/pubmed/31106840 http://dx.doi.org/10.5603/CJ.a2019.0051 |
Ejemplares similares
-
Variation in Practice Regarding Pretreatment With Dual Antiplatelet Therapy for Patients With Non–ST Elevation Myocardial Infarction
por: Shafiq, Ali, et al.
Publicado: (2016) -
Catalpol pretreatment attenuates cardiac dysfunction following myocardial infarction in rats
por: Bi, Fangjie, et al.
Publicado: (2018) -
Significance of antiplatelet therapy in emergency myocardial infarction treatment
por: Komosa, Anna, et al.
Publicado: (2014) -
Effects of Pinocembrin Pretreatment on Connexin 43 (Cx43) Protein Expression After Rat Myocardial Ischemia-Reperfusion and Cardiac Arrhythmia
por: Zhang, Peng, et al.
Publicado: (2018) -
Mouse models of myocardial infarction: comparing permanent ligation and ischaemia-reperfusion
por: De Villiers, Carla, et al.
Publicado: (2020)